• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区一项针对乳腺癌女性使用中医药的全国性横断面研究。

Use of Chinese medicine by women with breast cancer: a nationwide cross-sectional study in Taiwan.

机构信息

School of Medicine, National Yang-Ming University, No. 155 Sec. 2 Li-Nong St., Peitou, Taipei, Taiwan.

出版信息

Complement Ther Med. 2011 Jun;19(3):137-43. doi: 10.1016/j.ctim.2011.04.001. Epub 2011 May 2.

DOI:10.1016/j.ctim.2011.04.001
PMID:21641518
Abstract

OBJECTIVES

The National Health Insurance (NHI) provided Western medicine (WM) and Chinese medicine (CM) in Taiwan. This study aims to explore CM use by women with breast cancer under NHI.

METHODS

Using NHI Research Database, a retrospective cross-sectional study was conducted. Women with breast cancer were identified by diagnosis codes. Their claims of CM and WM outpatient services of 2007 were analyzed.

RESULTS

Among 70,012 female breast cancer patients, the prevalence of insurance covered CM was 35.6%. Among all CM users, 4379 (17.5%) patients visited CM for breast cancer. More than half CM users (67.6%) had less than 6 visits and 16.3% users had more than 12 visits. The majority of CM users (87.6%) also used WM ambulatory services. Private clinics (76.7%) provided the most CM services, followed by private hospitals (16.9%). The most frequently used CM therapies were Chinese herbal medicine (80.5%), followed by acupuncture/traumatology manipulative therapies (22.3%). The average cost of CM was US$17.6 per visit and US$119.7 per user annually. CM users were more likely to be younger than 60 years old, employees, with higher income, and not living in Northern Taiwan.

CONCLUSIONS

A significant portion of breast cancer patients used insurance covered CM. Most CM users also used WM. The potential of drug-herb interactions should be concerned.

摘要

目的

台湾的全民健康保险(NHI)提供西医(WM)和中医(CM)服务。本研究旨在探讨 NHI 下女性乳腺癌患者对 CM 的使用情况。

方法

使用 NHI 研究数据库,进行回顾性横断面研究。通过诊断代码确定乳腺癌女性患者。分析了 2007 年 CM 和 WM 门诊服务的报销情况。

结果

在 70012 名女性乳腺癌患者中,CM 保险覆盖的患病率为 35.6%。在所有 CM 用户中,有 4379 名(17.5%)患者因乳腺癌就诊于 CM。超过一半的 CM 用户(67.6%)就诊次数少于 6 次,16.3%的用户就诊次数超过 12 次。大多数 CM 用户(87.6%)也使用 WM 门诊服务。私人诊所(76.7%)提供最多的 CM 服务,其次是私人医院(16.9%)。最常使用的 CM 疗法是中草药(80.5%),其次是针灸/推拿疗法(22.3%)。CM 每次就诊的平均费用为 17.6 美元,每年每位用户的费用为 119.7 美元。CM 用户更可能年龄小于 60 岁、为员工、收入较高,且不住在台湾北部。

结论

相当一部分乳腺癌患者使用了保险覆盖的 CM。大多数 CM 用户也使用 WM。应关注药物-草药相互作用的潜在风险。

相似文献

1
Use of Chinese medicine by women with breast cancer: a nationwide cross-sectional study in Taiwan.台湾地区一项针对乳腺癌女性使用中医药的全国性横断面研究。
Complement Ther Med. 2011 Jun;19(3):137-43. doi: 10.1016/j.ctim.2011.04.001. Epub 2011 May 2.
2
Prevalence, patterns, and costs of Chinese medicine use among prostate cancer patients: a population-based study in Taiwan.台湾地区基于人群的研究:前列腺癌患者中中医药使用的流行率、模式和费用。
Integr Cancer Ther. 2010 Mar;9(1):16-23. doi: 10.1177/1534735409359073.
3
Trends in Chinese medicine use among prostate cancer patients under national health insurance in Taiwan: 1996-2008.台湾地区全民健康保险制度下前列腺癌患者的中医药使用趋势:1996-2008 年。
Integr Cancer Ther. 2011 Dec;10(4):317-27. doi: 10.1177/1534735410392576. Epub 2011 Mar 7.
4
Use of Chinese medicine among prostate cancer patients in Taiwan: a retrospective longitudinal cohort study.台湾地区前列腺癌患者使用中医药的情况:一项回顾性纵向队列研究。
Int J Urol. 2011 May;18(5):383-6. doi: 10.1111/j.1442-2042.2011.02738.x. Epub 2011 Mar 9.
5
Patterns of traditional Chinese medicine use in patients with inflammatory bowel disease: a population study in Taiwan.炎症性肠病患者的中医用药模式:台湾的一项人群研究。
Hepatogastroenterology. 2008 Mar-Apr;55(82-83):467-70.
6
Use of Chinese medicine among colorectal cancer patients: a nationwide population-based study.结直肠癌患者使用中药情况:一项基于全国人群的研究。
Afr J Tradit Complement Altern Med. 2014 Jan 28;11(2):343-349. doi: 10.4314/ajtcam.v11i2.20. eCollection 2014.
7
Prescription pattern of traditional Chinese medicine for climacteric women in Taiwan.台湾地区围绝经期妇女的中医药处方模式。
Climacteric. 2009 Dec;12(6):541-7. doi: 10.3109/13697130903060081.
8
The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database.台湾地区中药产品的处方用药情况:基于全民健康保险报销数据库的横断面分析
Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):609-19. doi: 10.1002/pds.1611.
9
Insurance covered and non-covered complementary and alternative medicine utilisation among adults in Taiwan.台湾成年人中保险涵盖与未涵盖的补充和替代医学使用情况。
Soc Sci Med. 2008 Oct;67(7):1183-9. doi: 10.1016/j.socscimed.2008.06.011. Epub 2008 Jul 22.
10
Utilization pattern of traditional Chinese medicine for liver cancer patients in Taiwan.台湾肝癌患者的中医药使用模式。
BMC Complement Altern Med. 2012 Sep 5;12:146. doi: 10.1186/1472-6882-12-146.

引用本文的文献

1
Quality of life and survival analyses of breast cancer cases treated with integrated traditional Chinese and Western medicine.中西医结合治疗乳腺癌病例的生活质量与生存分析
World J Clin Cases. 2024 Jul 16;12(20):4074-4081. doi: 10.12998/wjcc.v12.i20.4074.
2
The Inhibitory Effect of Kerra, KS, and Minoza on Human Papillomavirus Infection and Cervical Cancer.Kerra、KS 和 Minoza 对人乳头瘤病毒感染和宫颈癌的抑制作用。
Medicina (Kaunas). 2023 Dec 14;59(12):2169. doi: 10.3390/medicina59122169.
3
Popularity of Traditional Chinese Medicine Use Among Breast Cancer Patients in North China: A Cross-Sectional Study.
中国北方乳腺癌患者使用中医药的情况:一项横断面研究。
Breast Cancer (Dove Med Press). 2023 Aug 10;15:577-589. doi: 10.2147/BCTT.S416998. eCollection 2023.
4
The intention of utilization and experience toward traditional Chinese medicine among breast cancer patients in the early and late stages: a qualitative study.乳腺癌早晚期患者对中医药的使用意愿和体验:一项定性研究。
BMC Complement Med Ther. 2023 Jul 7;23(1):226. doi: 10.1186/s12906-023-04054-0.
5
The Use of San-Huang-Xie-Xin-Tang Reduces the Mortality Rate among Breast Cancer Patients.三黄泻心汤的使用降低了乳腺癌患者的死亡率。
Cancers (Basel). 2023 Feb 14;15(4):1213. doi: 10.3390/cancers15041213.
6
Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.艾杜清方通过抑制 TAM/CXCL1 诱导的 Treg 分化和浸润来抑制乳腺癌转移。
Cell Commun Signal. 2021 Aug 30;19(1):89. doi: 10.1186/s12964-021-00775-2.
7
Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.癌症患者中使用草药的患病率:一项系统评价和荟萃分析。
Evid Based Complement Alternat Med. 2021 May 17;2021:9963038. doi: 10.1155/2021/9963038. eCollection 2021.
8
Association between cancer-related fatigue and traditional Chinese medicine body constitution in female patients with breast cancer.乳腺癌女性患者癌因性疲乏与中医体质的相关性
J Tradit Complement Med. 2020 Aug 31;11(1):62-67. doi: 10.1016/j.jtcme.2020.08.005. eCollection 2021 Jan.
9
A population-based case-control study on the association of exposure with risk of breast cancer.一项基于人群的病例对照研究,探讨暴露因素与乳腺癌风险之间的关联。
J Tradit Complement Med. 2019 Oct 23;10(5):454-459. doi: 10.1016/j.jtcme.2019.10.003. eCollection 2020 Sep.
10
XIAOPI Formula Inhibits Breast Cancer Stem Cells Suppressing Tumor-Associated Macrophages/C-X-C Motif Chemokine Ligand 1 Pathway.消痞方通过抑制肿瘤相关巨噬细胞/C-X-C基序趋化因子配体1通路来抑制乳腺癌干细胞
Front Pharmacol. 2019 Nov 15;10:1371. doi: 10.3389/fphar.2019.01371. eCollection 2019.